Actively Recruiting
Study on Leucine and Polyunsaturated Fatty Acids Supplements to Improve Muscle Health in Adults Aged 50 to 99
Led by Chang Gung Memorial Hospital · Updated on 2025-06-22
90
Participants Needed
1
Research Sites
1 weeks
Total Duration
AI-Summary
What this Trial Is About
Population aging is a major global issue, and Taiwan is expected to become a super-aged society by 2025. As people age, physiological functions decline, including muscle mass loss, which is crucial in the aging process. This trial studies the effects of supplementing leucine-rich protein combined with polyunsaturated fatty acids on muscle health in individuals aged 50 and older who are at high risk for sarcopenia. Participants are randomly assigned to one of two groups one receives animal-based polyunsaturated oil supplementation, and the other receives plant-based polyunsaturated oil supplementation. Both groups will maintain their assigned supplementation for 12 weeks. The study is double-blinded to ensure unbiased results. During the study, muscle mass, muscle function, and physical function will be measured at the start and after 12 weeks of supplementation. These assessments will help researchers evaluate how the supplements affect muscle health. The trial is sponsored by Chang Gung Memorial Hospital and includes ongoing monitoring throughout the 12-week period.
CONDITIONS
Brief Title
Effects of Nutritional Supplementation of Leucine and Polyunsaturated Fatty Acids on Muscle Health in the Elderly
Research Team
H
Hsiang-Yu Tang, Ph.D.
Y
Yi Tsang Chen, Master of Science
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here